ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis

Summary

This study will evaluate the safety and efficacy of ATSN-201 in subjects ≥ 6 years of age with RS1-associated X-linked retinoschisis (XLRS).

Timeline

Start

2023-08-22

Primary completion

2028-04

Completion

2033-04

Drugs

Indications